🔗 Visit the ClinicalTrials.gov page for NCT00520481
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Drug resistance in metastatic castration-resistant prostate cancer. | Nat Rev Clin Oncol | 2010 | 1.86 |
| 2 | Overcoming drug resistance and treating advanced prostate cancer. | Curr Drug Targets | 2012 | 0.95 |
| 3 | Growth factor and signaling pathways and their relevance to prostate cancer therapeutics. | Cancer Metastasis Rev | 2014 | 0.92 |
| 4 | Emerging molecularly targeted therapies in castration refractory prostate cancer. | Prostate Cancer | 2013 | 0.83 |
| 5 | Modulation of insulin-like growth factor-1 receptor and its signaling network for the treatment of cancer: current status and future perspectives. | Oncol Rev | 2013 | 0.79 |
| 6 | Prolonged Response to an IGF-1 Receptor Antibody in a Patient with Metastatic Castration Prostate Cancer with Neuroendocrine Differentiation. | Cureus | 2015 | 0.75 |